| Literature DB >> 18304811 |
Christine Radanyi1, Gaëlle Le Bras, Samir Messaoudi, Céline Bouclier, Jean-François Peyrat, Jean-Daniel Brion, Véronique Marsaud, Jack-Michel Renoir, Mouâd Alami.
Abstract
A new series of coumarin inhibitors of hsp90 lacking the noviose moiety as well as substituents on C-7 and C-8 positions of the aromatic ring was synthesised and their hsp90 inhibitory activity has been delineated: for example, their capacity to induce the degradation of client proteins and to inhibit estradiol-induced transcription in human breast cancer cells. In cell proliferation assay, the most active compound 5g was approximately 8 times more potent than the parent novobiocin natural compound.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18304811 DOI: 10.1016/j.bmcl.2008.01.128
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823